Menu

FibroGen, Inc. FGEN

Full chart Compare
Set alert

Price alert · FGEN

All alert types
9.07 USD 0.00 (+0.00%)

Jan 12, 2026, 9:30 AM EST

9.02 Day range 9.21

52-week range unavailable

YTD
+3.30%
1 year
-41.90%

Revenue & Expenses

Other Income → Expenses: $110.81MExpenses → Selling, General & Admin: $49.33MExpenses → Research & Development: $95.69MExpenses → Other Operating Expenses: $19.45MExpenses → Interest Expense: $8.25MIncome Tax Benefit → Expenses: $269.00KGross Profit → Expenses: $14.06MRevenue → Gross Profit: $14.06MRevenue → Cost of Revenue: $15.56MNet Loss → Expenses: $47.58MOther Income$110.81MIncome Tax Benefit$269.00KGross Profit$14.06MNet Loss$47.58MCost of Revenue$15.56MExpenses$172.72MSelling, General & Admin$49.33MResearch & Development$95.69MOther Operating Expenses$19.45MInterest Expense$8.25MRevenue$29.62M

Latest period ending Dec 31, 2024 · select a line to chart its full history

FGEN annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
29.62M46.80M140.73M235.31M176.32M
14.06M42.84M120.45M222.44M167.45M
-150.42M-322.72M-301.02M-288.53M-191.88M
-47.58M-284.23M-293.65M-290.02M-189.29M
-12.00-73.00-78.00-78.00-53.00
FGEN annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
50.48M81.55M155.70M171.22M678.39M
214.53M423.53M610.09M773.82M826.84M
398.16M585.73M611.57M544.71M385.39M
131.96M201.03M139.22M99.72M39.76M
-225.60M-204.17M-21.45M209.15M422.18M
FGEN annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-138.00M-315.02M-145.93M-82.23M81.60M
125.99M153.66M89.12M-426.97M452.49M
-255.00K122.75M46.78M-563.00K13.34M
780.00K-2.52M-3.73M-5.19M-3.99M
-11.51M-42.01M-15.52M-507.17M552.13M